1/208
Year 2 Semester 1
what is pharmacodynamics
what the dryg does to the patient based on target interaction and downstream signaling
what is required for a clinical efffect
PK and PD- enough drug has to reach the target and then produce desired response
define onset
how quick can the target change cell function
define selectivity
which tissues express the target, and what else can the drug bind
define adverse effects
what predictable responses occur on non-target tissues
define interactions
do other drugs converge on the same target or system?
list and explain 2 general ways drug produce effects
prediction
dose
target mediated
target distribution and affinity shape the effect
higher dose often recruits additional targets
predictable
Physiochemical
location and physical chemistry shape the effect
dose effects may be broad but local delivery focuses them
major molecular targets
receptors
ion channels
enzymes
transport proteins
DNA and structural proteins
relationship between drugs and receptors
receptors usually work only on endogenous mediators
drugs can activate or block the receptors
same receptor may have desired effect in one tissue and adverse effect in another
name 4 receptor superfamilites
ligand-gated ion channel
G protein coupled receptor
enzynmes linked receptor
intracellular receptor
what recepotor class is neuromuscular blockage, explain
ligand gated ion channel
rapid
atracurium antagonize nicotinic ACh receptors
what recepotor class is sedation and anxiolysis, explain
.ligand gated ion channel
benzodiazepine positively modulate GABA receptors
rapid
what recepotor class is dissociative anesthesia, explain
ligand gated ion channel
rapid
ketamine block NMDA-type glutamate receptors
does fast signalling guarantee immediate clinical effect
no, route, perfusion, and distribution determine when the drug reaches the receptor
what recepotor class is andrenergic receptors, explain
GPCR
sec to min
epinephrinephrine support blood pressure and bronchodialation
what recepotor class is alpha 2 receptors, explain
GPCR
sec to min
dexmedetomidine produces sedation and analgesia
atipamezole reverses it
what recepotor class is opoid receptors , explain
GPCRs
seconds to mins
moprhine and fetanyle provide analgesia but can depress respiration
example of enzyme linked recepotrs and how long it takes for a response
insulin receptor: tyrosine kinase
mine: signal promotes glucose uptake and alters metabolism
hours: changes in gene expression influence growth and longer term adaptation
does one receptor work only on one time scale
no, one recpetor can generate effects on more than 1 time scale
describe function of intracellular recepotrs with lcoation, mecahnism, and clinical implications
alter gene transcription in hours to days
location: cytosol or nucleus
mechanism: receptor ligand complexes regulate transcription and protein synthesis
clinical implications: anti-inflammatory effects develop over hours
what determines onset
target signaling
PK: drug delivery and patient factors
mechanism sets. the biological top for speed
PK determines when target engagement occurs
what does sensitivity depend on
concentration
at lower concentration, drug can mainly occupy high affinity target
increase concentration, go to off target effects = more likely adverse effects
not specific
define allosteric ligand
bind at distinct site and changes receptor behavior ex. midazolam binds at seperate site and strengthens receptor’s response to GABA - not replace GABA
define orthosteric ligand
binds at endogenous agonist site, competes with endogenous ligand
example of drug working on voltage gated channels
dependence of channels
toxicity
administration
lidocane blocks voltage gated sodium channels and prevents action potential propagation- because cannot get polarization = animal does not know what is happening there
channels that open frequently can be blocked more effectively
excess exposure can cause impact on cardiac and CNS sodium channels
local administaration concentrates effect near intended nerves and limits systemic exposure
define drug action: target mediated
drug has receptor it is working on selectively
define drug action: primarily physiochemical
drug does not have a direct target but causes changes
3 examples of enzynme inhibition changing mediator production or breakdown
COX inhibiotrs: carprofen or meloxicam reducing prostanoid synthesis
acetylcholinesterase inhibitors: slow acetylcholine breakdown
phosphodiesterase inhibitors: slow cAMP breakdown and other actions
what does the enzyme inhibitor that changes mediator production or breakdown depend on
mediator turnover and downstream physiology
how is enzyme inhibition used for myasthenia gravis
used for diagnosis becuase disease attacks nicotinic ACh receptors
acetylcholinesterase inhibitor drug raising acetylcholine at the junction by reducing the amount destroyed
observe increase in strength = diagnosis
short acting so not therapeutic
excess stimulation causes weakness and muscarinic signs
give examples of how transport proteins control extracellular and intracellular concentrations
fluoxetine: block serotonin transporter, increasing extracellular serotonin
digoxin: inhibit Na/K ATPase increasing intracellular Ca in cardiomyocytes
note: all these require build up and time to get there for symptoms
examples of anticancer drugs targeting DNA processing or cell division and major concenrn
doxorubicin
vincristine
concern: high efficacy against dividing cells explains damage to normal tissues with rapid turnover
give 4 examples of physicochemical actions and what is required for them all
mannitol: raise tubular or plasma osmolarity
antacids: neutralize gastric acid
activated charcoal: absorb many toxins in GI tract
chelators: bind metals and promotes elimination
protectants: form local barrier
differences of ionophore use in species
monensin binds to sodium and carries across membranes
disrupts electrochemical gradients without active transport
used for benefits in cows
can be very harmful in horses
patient factors altering pharmacodynamic response
species sensitivity
disease state
age
physiology
tolerance
adaptation
why would you want to use epinephrine over dexamethasone in an emergy situation
epinephrine: active GPCRs which is rapid
Dex: activate intracellular glucocorticoid receptors which takes a long time
why can highly selective drugs still cause adverse effects at therapeutic dose (3)
the intended target may also be expressed in non target tissues
the desired physiological response may become excessive
higher exposure may recruit additional targets
how do drugs bind to receptors
shape and chemical complementarity forming a reversible complex that produces a biological effect
how do agonists work
bind and activate the receptor
stabilize active conformation
produce response
how do antagonists work
bind receptor but do not activate
prevent response
define affinity
ability to bind to receptor
high = bind tight and stay bound even at low concentrations
low = bind weak and lets go easily, needs higher concentrations to bind
define intrinsic efficacy
ability to activate the receptor
describe the difference between partial and full agonist
partial: slightly activate = low efficacy
full: fully activate = high efficacy
what are the 3 levels of efficacy
receptor: how well the drug activates the receptor
cellular: how well that action produces a cellular response
clinical: how well the drug produces a therapeutically useful effect in the whole animal
what is the efficacy of antagonist
none, no intrinsic efficacy becuase they do not activate a receptor though they can still produce an effect on the whole animal (real clinical efficacy)
does antagonist have affinity
yes, just no efficacy
what is the measure of affinity
Kd
the concentration of drug required to occupy 50% of the receptors at equilibrium
dissociation constant
what does a lower Kd mean
higher affinity
less drug is needed to fill half the receptors meaning the drug binds more easily
what does the rate of affinity depend on
concentration, more drug and receptor present, faster they combine
are most drug binding permanent
no, most are reverible/ non covalent
ionic interactions (strongest)
hydrogen bonds
hydrophobic interactions
van der waals forces (weakest)
when are drug bindings perminant
with covalent bonds- lasts until the body makes new receptor or enzyme not until the drug is cleared
organophosphates
asprin
why does drug binding follow the law of mass action
because many weak bonds togetehr hold the drug in place and let it go again
what does Kd tell you
affinity of the drug fro its receptor
inversible proportional to affinity
concentration where 50% of receptors are occupied
what does Kd tell you about efficacy
nothing
do antagonist or agonists have Kd
both
what does potency refelect
drug and receptor binding and what happens after the drug binds, not the affinity
what is efficacy
max possible effect a drug can produce regardless of the amount given
how is efficacy measured
Emax
higher = more efficacious
why would you want. to use a partial agonist instead of a full agonist
sometimes the partial is enough effective and has less adverse effects
when does binding = effect
not always
Kd=EC50
half the receptors occupied gives half the effect
Kd>ED50
full effect before all the receptors are occupied
Kd<EC50
no effect until most receptors are occupied
how is effect measured
EC50
what does Kd>EC50 usually suggest
agonist
what does Kd<EC50 usually mean
antagonist
needs to displace and agonist to get effect
must block most receptors
or enzyme inhibitor at non rate limiting step that must block enzyme first
antagonist EC50
do not have one because their effect is inhibition
use IC50= concentration that blocks 50% of an agonist response/ half maximal inhibitory concentration
what does a lower IC50 mean
higher potency - less drug needed
what does IC50 measure
function inhibition not binding affinity
define potency
how much drug is needed to produce given effect
how is potency measured
EC50 (50% the max response), lower= more potent

which drug is more potent and which is more effective
potent: A
effective: all the same

which drug is more potent, which is more effective
potent: A
effective: B
difference between potency and clinical efficacy
potency: concentration of drug needed to produce effect depending on EC50 and if the drug gets to the receptors
clinical efficacy: if the response solves the problem depending on size of max response
can a low potency drug ever cause the same effect as a high potency drug
yes, just at a much higher dose
advantages of high potency drugs
smaller mounts needed for effect
useful when injection volume is limited: darting
more convenient and cost effective
disadvantages to high potency drugs
higher risk of toxicity/overdose
narrower margin of saftey
dose errors can have serous consequences (require careful dosing, easy to overdose)
what does potency depend on
affinity and efficacy
out of affinity, potency, and efficacy, which is most important clinically
efficacy because potency only sets the dose
define selectivity and how changes can shift it
drug prefers some receptors to other for binding
dopamine receptors are highly sensitive but adding a tiny OH can change the receptor choice completly
how does the fit of drugs affect potencies
poor fit = must less active with different stereoisomer potencies
significance of levamisole
anti-nematode agent that makes a cocane high feel higher
2 rules of drug selectivity
nothing is totally selective
some drugs are more selevtive than others (more selective = wider gate between effective and toxic concentrations)
3 key characteristics of receptors
allosteric proteins: binding at one site changes conformation and activity
shift between inactive and active conformations
most unoccupied receptors are inactive (resting) state
difference in speed of ligand gated ion channel and G protein coupled receptor
ion channel is faster because just have ligant bind and then channel opens (milliseconds)
G protein coupled receptor is slower because it causes a cascade of effects
ionotrophic receptor- describe channel and mechanism
channel is the receptor with a central pore
mechanism: ligand binding changes receptor shape so pore opens
common effects of ionotropic receptors
Na or Ca causes depolarization (excitatory)
Cl- in causes hyperpolarization (inhibitory)
what is long term potentiation
after strong activity, a synapse responds more strongly to the same signal (cellular biased memory)
insertion of receptors
modify receptors to be more efficient
increase neurotransmitter
speed of metabotrophic receptors
slower, but greater amplitude, many G proteins activated at once
speed of intracellular receptors
hours to days, but long lasting effects
speed of enzyme linked receptors
minuets to hours, control growth, survival, plasticity
define partial agonist
binds and activated the receptor, produces less than maximal response even when every receptor is occupied (lower efficacy)
what is the ceiling effect on an agonist
after a certian dose, more drug adds no more effect
effect of partial agonist next to full agonist
acts like an antagonist becuase it occupies receptors but only partially activates them so there is a decrease in full agonist effect
describe function of inverse agonist
binds and stabilized inactive conformation, shifting the balance away from the active state
what is the difference between an inverse agonist and a neutral antagonist
neutral antagonist blocks agonists but leaves baseline activity unchanged
inverse agonist pushed activity below the baseline
3 ways antagonists block a drugs effect
Pharmacological: on the same receptor: bind receptor without activiating it so the agonist cannot
physiological: activate a different receptor or pathway to produce the opposite effect, same tissue, different pathway, different organ
pharmacokinetic: keeps the drug from reaching the target through binding, blocking absorption, or speeding up elimination
what can an antagonist do on its own
nothing, only shows effect when agonist is present
compare affinity and efficacy:
agonist
partial agonist
antagonist
agonist: affinity and efficacy
partial agonist: affinity and some efficacy
antagonist: affinity, no efficacy
describe funciton of competitive antagonist
binds the same site as the agonist, binding is reversible and enough agonist can outcompete it
describe funciton of non competitive antagonist
bind irreversibly or at a different site from the agonist
the agonist cannot compete it off
example of physiological antagonist to histamine
histamine on H1 receptor causes airways to narrow
epinephrine on beta2 receptor causes airways to open
when are physiological antagonists useful
when the cause is unknown- don’t know what drug is causing the signs, just want to cause opposite physiological effect